Live
CellHyperinnervation inhibits organ-level regeneration in mammalian skinCellDeciphering mechanical determinants of morphological evolutionCellAn activated wheat CC<sub>G10</sub>-NLR immune receptor forms an octameric resistosomeCellThe E3-ome gene-centric compendium reveals the human E3 ligase landscapeEndpoints NewsRoche, Nvidia’s 'AI Factory'; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and moreWaters3,833 Shares in Waters Corporation $WAT Bought by AIA Group Ltd - MarketBeat10x Genomics Blog10x Genomics Stock Analysis: Recent Gains vs. Long-Term Growth Challenges | 2026 - News and Statistics - IndexBox10x Genomics Blog3 Factors to Consider for Selling TXG and One Alternative Stock Worth Purchasing - Bitget10x Genomics Blog3 Reasons to Sell TXG and 1 Stock to Buy Instead - Yahoo FinanceThermo FisherEU Commission clears acquisition of Clario by Thermo Fisher - INSIGHT EU MONITORINGThermo FisherEU Commission clears acquisition of Clario by Thermo Fisher - INSIGHT EU MONITORINGAgilentAgilent (NYSE: A) holders back board declassification and pay votes - Stock Titan
BioPharma Dive Jan 21, 2026

J&J eyes $100B in sales amid gains for cancer, immune drugs

J&J eyes $100B in sales amid gains for cancer, immune drugs

Original
Body unavailable. Use the original source.

Directory

59 All